# The ASCEND Study: A Study to Investigate the Safety and Clinical Effect of Nexagon to Treat Slow Healing Diabetic Foot Ulcers

> **NCT00820703** · PHASE1,PHASE2 · TERMINATED · sponsor: **OcuNexus Therapeutics, Inc.** · enrollment: 24 (estimated)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **DRUG:** Nexagon®
- **DRUG:** Nexagon® vehicle

## Key facts

- **NCT ID:** NCT00820703
- **Lead sponsor:** OcuNexus Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-04
- **Primary completion:** 2009-11
- **Final completion:** 2009-12
- **Target enrollment:** 24 (ESTIMATED)
- **Why stopped:** For business reasons
- **Last updated:** 2010-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00820703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00820703, "The ASCEND Study: A Study to Investigate the Safety and Clinical Effect of Nexagon to Treat Slow Healing Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00820703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*